DJIA 18,162.99 121.45 0.67%
NASDAQ 5,106.59 73.84 1.47%
S&P 500 2,123.48 19.28 0.92%
market minute promo

BioMarin Pharmaceutical (NASDAQ: BMRN)

129.54 2.43 (1.91%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BMRN $129.54 1.91%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $128.12
Previous Close $127.11
Daily Range $127.02 - $131.54
52-Week Range $55.36 - $133.54
Market Cap $20.8B
P/E Ratio -118.79
Dividend (Yield) $0.00 (0.0%)
Volume 1,718,399
Average Daily Volume 1,183,021
Current FY EPS -$2.14




Drug Makers

BioMarin Pharmaceutical (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website:

News & Commentary Rss Feed

Did BioMarin Bet on the Wrong Experimental DMD Drug?

Sarepta Therapeutics may hold a key advantage over BioMarin in the race to bring a game-changing Duchenne muscular dystrophy drug to market. Here's why.

Wednesday's ETF Movers: BBH, XOP

Insider Trading Alert - WASH, BMRN And AAP Traded By Insiders

Analyst Has 4 Top US Growth Stock Calls for This Week

Merck KGaA-BioMarin's Kuvan may Undergo Label Update - Analyst Blog

Merck KGaA-BioMarin's Kuvan may Undergo Label Update - Analyst Blog

Uh-Oh! Billionaire George Soros Just Stepped on Another Biotech Landmine

George Soros is one of the most closely watched figures in the investing world. Retail investors, though, shouldn't necessarily take cues from his hedge fund. Here's why.

Upcoming Events: A Dosing Decision For BioMarin, Plus Roche To Get Alzheimer's Data

'Fast Money' Recap: HP's Mixed Bag, Questions for GAP, Apple's Upswing

Sarepta to Finish Eteplirsen Regulatory Filing by Mid-15 - Analyst Blog

See More BMRN News...

BMRN's Top Competitors

BMRN $129.54 (1.91%)
Current stock: BMRN
CELG $116.02 (1.36%)
Current stock: CELG
AMGN $160.44 (0.90%)
Current stock: AMGN
BIIB $402.92 (2.56%)
Current stock: BIIB